Publicaciones en las que colabora con Carmen Mora Fernández (15)

2024

  1. FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 10

2022

  1. Electronic Patient-Reported Outcomes in Nephrology: Focus on Hemodialysis

    Journal of Clinical Medicine, Vol. 11, Núm. 3

  2. Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease

    Scientific Reports, Vol. 12, Núm. 1

2020

  1. Association between serum levels of Klotho and inflammatory cytokines in cardiovascular disease: a case-control study

    Aging, Vol. 12, Núm. 2, pp. 1952-1964

  2. Inflammatory targets in diabetic nephropathy

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. Fibroblast growth factor 23 expression in human calcified vascular tissues

    Aging, Vol. 11, Núm. 18, pp. 7899-7913

  2. Pentoxifylline for renal protection in diabetic kidney disease. A model of old drugs for new horizons

    Journal of Clinical Medicine, Vol. 8, Núm. 3

2017

  1. Anti-inflammatory profile of paricalcitol in kidney transplant recipients

    Nefrologia, Vol. 37, Núm. 6, pp. 622-629

  2. Soluble levels and endogenous vascular gene expression of KLOTHO are related to inflammation in human atherosclerotic disease

    Clinical Science, Vol. 131, Núm. 21, pp. 2601-2609

2015

  1. Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: The PREDIAN trial

    Journal of the American Society of Nephrology, Vol. 26, Núm. 1, pp. 220-229

2001

  1. Intoxicación por paraquat: Presentación de dos casos y revisión de la literatura

    Anales de Medicina Interna, Vol. 18, Núm. 4, pp. 208-210

1998

  1. Androgens for the treatment of anemia in peritoneal dialysis patients.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 14, pp. 232-235

1997

  1. Effects of angiotensin-converting enzyme inhibitors on anemia and erythropoietin requirements in peritoneal dialysis patients.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 13, pp. 257-259

  2. Hemodialysis urea rebound and membrane biocompatibility: Accuracy of Kt/V estimations

    Artificial Organs, Vol. 21, Núm. 2, pp. 91-95

  3. Urticarial anaphylactoid reaction following metoprolol [2]

    Clinical Nephrology